RACHELLE BANDINO: Open Payments
NPI 1619621745 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,758 in 89 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $30 · 2025 $1,758
Food & beverage: $1,758
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $255 |
| LEO Pharma Inc. | 11 | $249 |
| Galderma Laboratories, L.P. | 6 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $197 |
| Novartis Pharmaceuticals Corporation | 6 | $157 |
| GENZYME CORPORATION | 8 | $155 |
| PFIZER INC. | 6 | $128 |
| UCB, Inc. | 4 | $63 |
| Incyte Corporation | 3 | $57 |
| Organon LLC | 6 | $54 |
Products named: NEMLUVIO, ADBRY, RINVOQ, DUPIXENT, ILUMYA, COSENTYX, CIBINQO, SKYRIZI.
Industry payments across TX — which companies pay providers there.
